☆ 4.7 Article

Development of a core outcome set for cardiovascular diabetology: a methodological framework

FRONTIERS IN ENDOCRINOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Individual or familial diabetes in relation to eight cardiovascular diseases: A two-sample Mendelian randomization study

Meng-Jin Hu et al.

Summary: This study investigates the causal relationships between diabetes and cardiovascular diseases using genetic predisposition. It finds that both individual and familial diabetes are associated with increased risks of myocardial infarction, hypertension, and ischemic stroke, highlighting the potential role of family history in cardiovascular disease prevention.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2023)

Add to Collection

Review Cell Biology

Diabetes and Its Cardiovascular Complications: Potential Role of the Acetyltransferase p300

Nadia Di Pietrantonio et al.

Summary: Diabetes accelerates vascular senescence, leading to chronic inflammation and oxidative stress, which in turn cause endothelial dysfunction and related cardiovascular complications. The acetyltransferase p300 has been suggested to play a crucial role in diabetes-associated inflammation and oxidative stress, potentially contributing to the development of vascular senescence. Understanding the mechanisms of p300 in diabetic vascular dysfunction could aid in finding new therapeutic strategies for cardiovascular diseases related to diabetes.

CELLS (2023)

Add to Collection

Article Cell Biology

The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes

Merlin C. Thomas et al.

Summary: Recent clinical trials have shown that GLP-1RAs can have positive effects on heart and kidney outcomes in people with type 2 diabetes. This is due in part to improved glucose control and significant weight loss, but GLP-1RAs may also provide additional benefits by improving postprandial dysmetabolism.

CELL METABOLISM (2023)

Add to Collection

Article Endocrinology & Metabolism

Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes

Moahad S. Dar et al.

Summary: This study used the diabetes staging system (DSS) to assess the association between disease stage and mortality rates in type 2 diabetes cardiovascular outcome trials, and found that higher DSS stage was associated with increased rates of all-cause mortality and cardiovascular death.

DIABETES OBESITY & METABOLISM (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss

Paola Simeone et al.

Summary: Liraglutide treatment can reduce sST2 levels and possibly have a positive effect on cardiac fibrosis in obese patients with prediabetes or early type 2 diabetes mellitus. Plasma Gal-3 levels before liraglutide treatment may predict the response to the drug in terms of beta cell function improvement.

CARDIOVASCULAR DIABETOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Developing a core outcome set for assessing clinical safety outcomes of cardiovascular diseases in clinical trials of integrated traditional Chinese medicine and Western medicine: study protocol

Ruijin Qiu et al.

Summary: This article presents the methodology for developing a core outcome set (COS) to assess safety outcomes in clinical trials of integrative medicine for cardiovascular diseases. Through Delphi surveys and a consensus meeting, the aim is to improve reporting consistency and identify potential bias in selective reporting.

TRIALS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia

Geng Li et al.

Summary: In this study, a core outcome set (COS) for Chinese medicine clinical trials for hyperlipidemia was developed to address the issue of outcome heterogeneity. Through a systematic review and a three-round Delphi survey, the most important outcomes for COS-CM-Hyperlipidemia were determined, including cardiovascular events, lipid levels, and cardiovascular disease risk.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Ethics

Development of a core outcome set for informed consent for therapy: An international key stakeholder consensus study

Liam J. Convie et al.

Summary: This study used a mixed-methods approach to define a core outcome set for informed consent for intervention, which is the first of its kind. It provides a step towards standardizing future consent research.

BMC MEDICAL ETHICS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effect of acute ketosis on lipid profile in prediabetes: findings from a cross-over randomized controlled trial

Yutong Liu et al.

Summary: The study found that acute ketosis had no adverse effects on plasma lipid profile and led to significantly reduced circulating levels of remnant cholesterol and triglycerides. Changes in remnant cholesterol and triglycerides were statistically significant in individuals with high habitual saturated fat intake.

CARDIOVASCULAR DIABETOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association between serum insulin levels and heart failure-related parameters in patients with type 2 diabetes and heart failure treated with canagliflozin: a post-hoc analysis of the randomized CANDLE trial

Atsushi Tanaka et al.

Summary: This study investigated the effect of canagliflozin on insulin concentrations in patients with T2D and HF, finding that canagliflozin treatment significantly reduced insulin concentrations and was associated with improvement in HF-related clinical parameters.

CARDIOVASCULAR DIABETOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)

Timothy M. E. Davis et al.

Summary: Short-term cardiometabolic responses to EQW were similar in the main racial groups in the Exenatide Study of Cardiovascular Event Lowering, except for a greater pulse rate increase in Asians.

CARDIOVASCULAR DIABETOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the Epilepsy outcome Set for Effectiveness Trials Project (EPSET)

James W. Mitchell et al.

Summary: The choice of outcomes in epilepsy clinical trials varies widely, contributing to research waste and hindering integration of findings. To address this, a Core Outcome Set (COS) specific to clinical effectiveness research for adults with epilepsy will be developed using Delphi consensus methodology. This will harmonize outcome measurement, ensure relevance to patients and health services, and facilitate meaningful results.

TRIALS (2022)

Add to Collection

Article Medicine, General & Internal

Development of a core outcome set on Traditional Chinese Medicine and Western Medicine for rheumatic heart disease: a study protocol

Xiaodi Sheng et al.

Summary: The study will be conducted in four stages under the guidance of a multidisciplinary advisory board. The research will involve establishing a comprehensive outcomes checklist, screening stakeholder groups, conducting two e-Delphi surveys, and holding a face-to-face consensus meeting to develop the COS-TCM-RHD. The ethical approval has been obtained and the findings will be disseminated in peer-reviewed journals and meetings.

BMJ OPEN (2022)

Add to Collection

Article Medicine, General & Internal

Development of a core outcome set in the clinical trials of traditional Chinese medicine for diabetic foot: A study protocol

Xin Yue Dai et al.

Summary: Diabetic foot is a common complication of diabetes, and traditional Chinese medicine treatment has certain advantages in addressing it. However, there is currently no core set of outcomes for measuring or monitoring diabetic foot with traditional Chinese medicine. Developing a core outcome set for traditional Chinese medicine in the treatment of diabetic foot is important for addressing these issues.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Critical Care Medicine

A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study

Daniel Munblit et al.

Summary: This international consensus study aims to identify the core outcomes of post-COVID-19 condition, providing a standardized assessment framework for clinical care and global research.

LANCET RESPIRATORY MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report

Lucia Leccisotti et al.

Summary: This study investigated the effects of SGLT-2 inhibition on myocardial perfusion and glucose metabolism in patients with type 2 diabetes and stable coronary artery disease. The results showed that SGLT-2 inhibition increased myocardial flow reserve and possibly improved coronary microvascular dysfunction.

CARDIOVASCULAR DIABETOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Development of a core outcome set for hypertensive intracerebral hemorrhage in clinical trials of traditional Chinese medicine: a study protocol

Min Jia et al.

Summary: This study aims to establish a core outcome set (COS) for future traditional Chinese medicine clinical trials of hypertensive intracerebral hemorrhage (HICH) to determine what outcomes should be reported, and when and how to measure them.

TRIALS (2022)

Add to Collection

Article Medicine, Research & Experimental

A protocol for developing core outcome sets for laparoscopic hiatal hernia repair

Xiaoli Liu et al.

Summary: This study aims to develop a core outcome set for laparoscopic hiatal hernia repair, providing unique assessment criteria for clinical research and improving comparative analyses among studies.

TRIALS (2022)

Add to Collection

Review Pediatrics

Core Outcome Sets in Child Health A Systematic Review

Ruobing Lei et al.

Summary: This study aimed to systematically review core outcome sets in child health and found a total of 77 pediatric core outcome sets. The quality of existing core outcome sets in this field is low, and future efforts should focus on improving methodology and reporting standards to enhance the quality of core outcome sets.

JAMA PEDIATRICS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach

Karolina Drozdz et al.

Summary: This study utilized machine learning techniques to identify the most important risk factors for cardiovascular disease in patients with MAFLD, leading to potential new research directions and methods.

CARDIOVASCULAR DIABETOLOGY (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

Ferdinando Carlo Sasso et al.

Summary: The post-hoc analysis of the NID-2 trial shows that an increase in the number of risk factors at target correlates with better cardiovascular-free survival in patients with type 2 diabetes at high cardiovascular risk.

CARDIOVASCULAR DIABETOLOGY (2022)

Add to Collection

Editorial Material Orthopedics

Using Evidence Hierarchies to Find the Best Evidence: A Procrustean Bed?

Thomas J. Hoogeboom et al.

PHYSICAL THERAPY (2021)

Add to Collection

Review Medicine, Research & Experimental

A core outcome set for clinical trials of first- and second-degree perineal tears prevention and treatment: a study protocol for a systematic review and a Delphi survey

Lin Xiao et al.

Summary: This study aims to develop a core outcome set for clinical trials of mild perineal tears, involving systematic literature research, interviews with key stakeholders, a Delphi survey by experts, and a consensus meeting to establish international standards for outcome measures, facilitating comparison of studies and improving perineal care for women during vaginal delivery.

TRIALS (2021)

Add to Collection

Article Medicine, Research & Experimental

Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement

Jamie J. Kirkham et al.

TRIALS (2019)

Add to Collection

Article Health Care Sciences & Services

What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences

Zachary Munn et al.

BMC MEDICAL RESEARCH METHODOLOGY (2018)

Add to Collection

Article Public, Environmental & Occupational Health

The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015

Florence van Hunsel et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)

Add to Collection

Editorial Material Geriatrics & Gerontology

The COMET (Core Outcome Measures in Effectiveness Trials) Initiative

Elizabeth Gargon

MATURITAS (2016)

Add to Collection

Review Medicine, General & Internal

Core Outcome Set-STAndards for Reporting: The COS-STAR Statement

Jamie J. Kirkham et al.

PLOS MEDICINE (2016)

Add to Collection

Article Medicine, General & Internal

Prospective registration, bias risk and outcome-reporting bias in randomised clinical trials of traditional Chinese medicine: an empirical methodological study

Jian-Ping Liu et al.

BMJ OPEN (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.